BRIEF-Kronos Bio Q4 EPS USD -0.43

Reuters
19 Mar
BRIEF-Kronos Bio Q4 EPS USD -0.43

Mar 18 (Reuters) - Kronos Bio Q4 operating expenses USD 29.424 million.

  • Q4 net income USD -25.813 million
  • Q4 operating income USD -27.154 million
  • Q4 basic EPS USD -0.43

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10